Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00049348Phase 2Completed
A Phase 2 trial of gemcitabine, fluorouracil, cisplatin in pancreatic adenocarcinoma (PDAC), sponsored by Eastern Cooperative Oncology Group. Started Oct 2003; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00049348.